[Impact of cytochrome P450 2C19 polymorphisms on outcome of cardiovascular events in clopidogrel-treated Chinese patients after percutaneous coronary intervention].

Zhonghua xin xue guan bing za zhi

Volumn 39, Issue 7, 2011, Pages 617-620

  Tang, Xiao Fang ^a   He, Chen ^b   Yuan, Jin Qing ^b   Meng, Xian Min ^b   Yang, Yue Jin ^b   Qin, Xue Wen ^b   Qiao, Shu Bin ^b   Liu, Hai Bo ^b   Wu, Yong Jian ^b   Yao, Min ^b   Chen, Jue ^b   You, Shi Jie ^b   Wu, Yuan ^b   Li, Jian Jun ^b   Dai, Jun ^b   Chen, Ji Lin ^b   Gao, Run Lin ^b   Chen, Zai Jia ^b  

^a FUWAI HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CYP2C19 PROTEIN, HUMAN; DRUG DERIVATIVE; TICLOPIDINE; UNSPECIFIC MONOOXYGENASE;

AGED; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ARYL HYDROCARBON HYDROXYLASES; CORONARY DISEASE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TICLOPIDINE;

EID: 84856286242     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)